<DOC>
	<DOCNO>NCT01604135</DOCNO>
	<brief_summary>The purpose study determine whether corneal collagen crosslinking effective treatment progressive keratoconus .</brief_summary>
	<brief_title>Collagen Crosslinking Keratoconus - Randomized Controlled Clinical Trial</brief_title>
	<detailed_description>Keratoconus noninflammatory , asymmetrical , progressive corneal ectasia cause biomechanical instability corneal stroma . Treatment modality primarily glass contact lens . It estimate one five patient progress extent corneal transplant necessary regain useful vision . Corneal collagen crosslinking ( CXL ) treatment modality intend halt progression keratoconus . This study investigate efficacy av CXL stabilize cornea keratoconus mean randomize controlled clinical trial . Participants eligible inclusion progressive keratoconus confirm inclusion criterion meet . Follow-up inclusion 1 week ( treatment group ) , 1 , 3 , 6 12 month . Pre- post-inclusion examination include measurement uncorrected distance visual acuity ( UCDVA ) , best spectacle correct distance visual acuity ( BSCDVA ) , Scheimpflug-topography slitlamp examination .</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>Keratoconus diagnosis determine clinically topographically ( KISA % index ) Significant progression define change ( increase ) Kmax least 1D baseline 6 month and/or change ( increase ) SimKast least 1D baseline 6 month . Kmax define steep radius curvature ( either maximum simulate Kreading maximum Kreading 3mm zone 5mm zone ) anterior corneal surface progress 6 month observation Ability stop contact lens ( rigid soft ) wear least two week prior next exam Signed write informed consent Age &lt; 18 year Pregnancy Breast feed History corneal surgery History ocular herpes simplex infection Minimal corneal thickness &lt; 300 micrometer Recurrent corneal erosion Other corneal ( e g endothelial ) conjunktival diseases Neurodermatitis Severe form av atopic disease Collagenoses , autoimmune systemic disease Systemic treatment high dos steroid Severe scar och stria cornea Relative exclusion criterion : Kmax &gt; 58D Minimal corneal thickness &lt; 400 micrometer ( modify CXLtreatment use swell cornea UVillumination treatment ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Collagen crosslinking</keyword>
	<keyword>Keratoconus</keyword>
</DOC>